• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度孟买的耐药结核病:运筹学议程

Drug-resistant tuberculosis in Mumbai, India: An agenda for operations research.

作者信息

Mistry Nerges, Tolani Monica, Osrin David

机构信息

The Foundation for Medical Research, 84A RG Thadani Marg, Worli, Mumbai 400 018, Maharashtra, India.

Center for International Health and Development, UCL Institute of Child Health, 30 Guildford Street, London WC1N 1EH, UK.

出版信息

Oper Res Health Care. 2012 Jun;1(2-3):45-53. doi: 10.1016/j.orhc.2012.06.001.

DOI:10.1016/j.orhc.2012.06.001
PMID:24501697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3836418/
Abstract

Operations research (OR) is well established in India and is also a prominent feature of the global and local agendas for tuberculosis (TB) control. India accounts for a quarter of the global burden of TB and of new cases. Multidrug-resistant TB is a significant problem in Mumbai, India's most populous city, and there have been recent reports of totally resistant TB. Much thought has been given to the role of OR in addressing programmatic challenges, by both international partnerships and India's Revised National TB Control Programme. We attempt to summarize the major challenges to TB control in Mumbai, with an emphasis on drug resistance. Specific challenges include diagnosis of TB and defining cure, detecting drug resistant TB, multiple sources of health care in the private, public and informal sectors, co-infection with human immunodeficiency virus (HIV) and a concurrent epidemic of non-communicable diseases, suboptimal prescribing practices, and infection control. We propose a local agenda for OR: modeling the effects of newer technologies, active case detection, and changes in timing of activities, and mapping hotspots and contact networks; modeling the effects of drug control, changing the balance of ambulatory and inpatient care, and adverse drug reactions; modeling the effects of integration of TB and HIV diagnosis and management, and preventive drug therapy; and modeling the effects of initiatives to improve infection control.

摘要

运筹学(OR)在印度已得到充分确立,并且也是全球和地方结核病(TB)控制议程的一个显著特征。印度承担了全球四分之一的结核病负担和新增病例。耐多药结核病是印度人口最多的城市孟买的一个重大问题,最近有关于完全耐药结核病的报道。国际伙伴关系和印度修订后的国家结核病控制规划都对运筹学在应对规划挑战方面的作用进行了深入思考。我们试图总结孟买结核病控制面临的主要挑战,重点是耐药性。具体挑战包括结核病的诊断和治愈标准的界定、耐多药结核病的检测、私营、公共和非正规部门多种医疗保健来源、与人类免疫缺陷病毒(HIV)的合并感染以及非传染性疾病的并发流行、不合理的处方做法以及感染控制。我们提出了一个运筹学的地方议程:对新技术的效果、主动病例发现以及活动时间安排的变化进行建模,绘制热点地区和接触网络;对药物控制的效果、改变门诊和住院治疗的平衡以及药物不良反应进行建模;对结核病和HIV诊断与管理的整合以及预防性药物治疗的效果进行建模;以及对改善感染控制措施的效果进行建模。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfbd/3930003/12199968f6dd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfbd/3930003/12199968f6dd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfbd/3930003/12199968f6dd/gr1.jpg

相似文献

1
Drug-resistant tuberculosis in Mumbai, India: An agenda for operations research.印度孟买的耐药结核病:运筹学议程
Oper Res Health Care. 2012 Jun;1(2-3):45-53. doi: 10.1016/j.orhc.2012.06.001.
2
Tuberculosis结核病
3
Tapping private health sector for public health program? Findings of a novel intervention to tackle TB in Mumbai, India.利用私营医疗部门服务公共卫生项目?印度孟买结核病新干预措施的发现。
Indian J Tuberc. 2020 Apr;67(2):189-201. doi: 10.1016/j.ijtb.2020.01.007. Epub 2020 Jan 22.
4
Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades?印度孟买私人执业医生的结核病管理:二十年来有何变化?
PLoS One. 2010 Aug 9;5(8):e12023. doi: 10.1371/journal.pone.0012023.
5
The Tuberculosis Cascade of Care in India's Public Sector: A Systematic Review and Meta-analysis.印度公共部门的结核病照护流程:一项系统评价与荟萃分析
PLoS Med. 2016 Oct 25;13(10):e1002149. doi: 10.1371/journal.pmed.1002149. eCollection 2016 Oct.
6
Variations in the quality of tuberculosis care in urban India: A cross-sectional, standardized patient study in two cities.印度城市结核病护理质量的差异:两个城市的横断面标准化患者研究。
PLoS Med. 2018 Sep 25;15(9):e1002653. doi: 10.1371/journal.pmed.1002653. eCollection 2018 Sep.
7
Treatment of childhood tuberculosis in India.印度儿童结核病的治疗
Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:43-46. doi: 10.5588/ijtld.15.0611.
8
RNTCP 2007: looking ahead to future challenges.《印度国家结核病控制规划(RNTCP)2007:展望未来挑战》 (注:这里RNTCP如果有特定全称,需根据其实际全称准确翻译,这里只是举例一种可能,因为没有更多背景信息)
J Indian Med Assoc. 2007 Apr;105(4):192, 194, 196.
9
Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.印度孟买大都市地区感染艾滋病毒患者中耐药结核病的惊人水平。
PLoS One. 2014 Oct 21;9(10):e110461. doi: 10.1371/journal.pone.0110461. eCollection 2014.
10
Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.印度修订国家结核病控制规划(2007-2011 年)下初始耐多药结核病(MDR-TB)患者中不可接受的治疗结果及相关因素:政策改进的依据。
PLoS One. 2018 Apr 11;13(4):e0193903. doi: 10.1371/journal.pone.0193903. eCollection 2018.

引用本文的文献

1
Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: A retrospective cohort study.印度孟买异烟肼单耐药结核病患者的治疗结果:一项回顾性队列研究。
J Clin Tuberc Other Mycobact Dis. 2024 Oct 12;37:100481. doi: 10.1016/j.jctube.2024.100481. eCollection 2024 Dec.
2
Assessment of the Occupational Risk of Tuberculosis & Air Borne Infection Control in High-Risk Hospital Wards and Its Implications on Healthcare Workers in a Tertiary Care Hospital in South India.印度南部一家三级护理医院高危病房结核病职业风险评估及空气传播感染控制及其对医护人员的影响
Cureus. 2023 Jan 15;15(1):e33785. doi: 10.7759/cureus.33785. eCollection 2023 Jan.
3

本文引用的文献

1
The unsurprising story of MDR-TB resistance in India.印度耐多药结核病耐药性的惊人故事。
Tuberculosis (Edinb). 2012 Jul;92(4):301-6. doi: 10.1016/j.tube.2012.02.009. Epub 2012 Apr 14.
2
MDR, XDR, TDR tuberculosis: ominous progression.耐多药、广泛耐药、全耐药结核病:不祥的进展。
Thorax. 2012 Apr;67(4):286-8. doi: 10.1136/thoraxjnl-2012-201663.
3
Operational research and MDG tuberculosis control targets.运筹学与千年发展目标结核病控制指标
Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India.
印度孟买复杂耐药结核病患者的精神共病情况。
PLoS One. 2022 Feb 11;17(2):e0263759. doi: 10.1371/journal.pone.0263759. eCollection 2022.
4
Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness.与私营医疗保健部门合作控制印度的结核病:成本和成本效益。
BMJ Glob Health. 2021 Oct;6(10). doi: 10.1136/bmjgh-2021-006114.
5
Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India.印度孟买常规结核项目中耐药结核病患儿和青少年的治疗结局。
PLoS One. 2021 Feb 18;16(2):e0246639. doi: 10.1371/journal.pone.0246639. eCollection 2021.
6
Diagnosis and Management of Osteoarticular Tuberculosis: A Drastic Change in Mind Set Needed-It is Not Enough to Simply Diagnose TB.骨与关节结核的诊断与管理:思维模式需彻底转变——仅诊断出结核病是不够的。
Indian J Orthop. 2020 Jul 25;54(Suppl 1):60-70. doi: 10.1007/s43465-020-00202-7. eCollection 2020 Sep.
7
Diagnosis of Osteoarticular Tuberculosis: Perceptions, Protocols, Practices, and Priorities in the Endemic and Non-Endemic Areas of the World-A WAIOT View.骨与关节结核的诊断:全球地方病流行区和非地方病流行区的认知、诊疗方案、实践及优先事项——世界骨与关节感染学会观点
Microorganisms. 2020 Aug 28;8(9):1312. doi: 10.3390/microorganisms8091312.
8
Mobile Health for Tuberculosis Management in South India: Is Video-Based Directly Observed Treatment an Acceptable Alternative?印度南部的移动医疗在结核病管理中的应用:基于视频的直接观察治疗是否可以作为一种可接受的替代方法?
JMIR Mhealth Uhealth. 2019 Apr 3;7(4):e11687. doi: 10.2196/11687.
9
Unfavourable outcomes among patients with MDR-TB on the standard 24-month regimen in Maharashtra, India.印度马哈拉施特拉邦耐多药结核病患者采用标准24个月治疗方案时的不良结局。
Public Health Action. 2017 Jun 21;7(2):116-122. doi: 10.5588/pha.17.0013.
10
Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India.印度孟买耐多药结核病高危人群的活动模式。
Int J Tuberc Lung Dis. 2016 Dec;20(12):1633-1638. doi: 10.5588/ijtld.16.0187.
Lancet Infect Dis. 2012 Apr;12(4):262-3. doi: 10.1016/S1473-3099(12)70034-8. Epub 2012 Mar 7.
4
Is operational research delivering the goods? The journey to success in low-income countries.运筹学是否有效?在低收入国家取得成功的历程。
Lancet Infect Dis. 2012 May;12(5):415-21. doi: 10.1016/S1473-3099(11)70309-7. Epub 2012 Feb 9.
5
Diagnosis & treatment of tuberculosis in HIV co-infected patients.HIV 合并感染患者的结核病诊断与治疗。
Indian J Med Res. 2011 Dec;134(6):850-65. doi: 10.4103/0971-5916.92630.
6
Antitubercular drug resistance in four healthcare facilities in North India.印度北部四家医疗机构中的抗结核药物耐药情况。
J Health Popul Nutr. 2011 Dec;29(6):583-92.
7
Totally drug-resistant tuberculosis in India.印度的完全耐药结核病
Clin Infect Dis. 2012 Feb 15;54(4):579-81. doi: 10.1093/cid/cir889. Epub 2011 Dec 21.
8
Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.印度孟买贫民窟中感染 HIV 的患者队列中,门诊耐多药结核病治疗结局。
PLoS One. 2011;6(12):e28066. doi: 10.1371/journal.pone.0028066. Epub 2011 Dec 1.
9
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.Xpert MTB/RIF assay 快速诊断高负担国家的结核病:成本效益分析。
PLoS Med. 2011 Nov;8(11):e1001120. doi: 10.1371/journal.pmed.1001120. Epub 2011 Nov 8.
10
Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India.印度安得拉邦诊断耐多药结核病和启动治疗方面的操作挑战。
PLoS One. 2011;6(11):e26659. doi: 10.1371/journal.pone.0026659. Epub 2011 Nov 2.